US Food and Drug Administration and FDA have decided to discard 60 million doses of Janssen's vaccine produced at the Baltimore plant in the US. It is because of a mixing accident, and it is known that the vaccine distributed in the United States is produced in the Netherlands.
Correspondent Kim Soo-hyung reports from Washington.
New York Times reported that the US Food and Drug Administration (FDA) has decided to dispose of 60 million doses of Janssen's coronavirus vaccine produced in Baltimore, USA.
This is in response to a vaccine component mixing accident at Immergent BioSolutions, a vaccine production plant located in Baltimore, in March.
At this plant, some raw materials for the Janssen vaccine and AstraZeneca vaccine were mixed, and 15 million doses of the Janssen vaccine at that time were discarded and the plant operation was suspended.
As a result of further investigation by the FDA, the decision was made to discard 60 million doses of other Janssen vaccines as there is a risk of contamination.
All Janssen vaccines currently distributed in the United States are produced in the Netherlands, the New York Times reported.
The FDA plans to authorize use of 10 million doses of the vaccine produced at the plant in question for distribution in the United States and for vaccine support abroad.
The decision to mass discard the Janssen vaccine is expected to necessitate some setbacks to President Biden's plan to support coronavirus vaccines abroad.